These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32924322)

  • 1. Improved 30 day heart failure rehospitalization prediction through the addition of device-measured parameters.
    Brown JR; Alonso A; Mazimba S; Warman EN; Bilchick KC
    ESC Heart Fail; 2020 Dec; 7(6):3762-3771. PubMed ID: 32924322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of serum albumin level and clinical outcomes among heart failure patients receiving cardiac resynchronization therapy].
    Yang SW; Liu ZM; Mi JR; Liu SY; Ding LG; Chen KP; Hua W; Zhang S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):204-208. PubMed ID: 28316176
    [No Abstract]   [Full Text] [Related]  

  • 3. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients.
    Eapen ZJ; Liang L; Fonarow GC; Heidenreich PA; Curtis LH; Peterson ED; Hernandez AF
    JACC Heart Fail; 2013 Jun; 1(3):245-51. PubMed ID: 24621877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy.
    Varma N; Auricchio A; Connolly AT; Boehmer J; Bahu M; Costanzo MR; Leonelli F; Yoo D; Singh J; Nabutovsky Y; Gold M
    Europace; 2021 Oct; 23(10):1586-1595. PubMed ID: 34198334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.
    Perego GB; Landolina M; Vergara G; Lunati M; Zanotto G; Pappone A; Lonardi G; Speca G; Iacopino S; Varbaro A; Sarkar S; Hettrick DA; Denaro A;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):235-42. PubMed ID: 18810621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
    Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
    J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
    Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM
    Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Status Predicts Short- and Long-Term Risk of Composite Clinical Outcomes in Acute Heart Failure.
    Hu D; Liu J; Zhang L; Bai X; Tian A; Huang X; Zhou K; Gao M; Ji R; Miao F; Li J; Li W; Ge J; He G; Li J
    JACC Heart Fail; 2021 Dec; 9(12):861-873. PubMed ID: 34509406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
    Kociol RD; Horton JR; Fonarow GC; Reyes EM; Shaw LK; O'Connor CM; Felker GM; Hernandez AF
    Circ Heart Fail; 2011 Sep; 4(5):628-36. PubMed ID: 21743005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes.
    Desai RJ; Wang SV; Vaduganathan M; Evers T; Schneeweiss S
    JAMA Netw Open; 2020 Jan; 3(1):e1918962. PubMed ID: 31922560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an Integrated Device Diagnostics Algorithm to Risk Stratify Heart Failure Patients　- Results From the SCAN-HF Study.
    Okumura K; Sasaki S; Kusano K; Mine T; Fujii K; Iwasa A; Sunagawa O; Yamabe H; Takahashi N; Ishii S; Takeishi Y; Tsuboi N; Shizuta S; Aonuma K; Shimane A; Tada H; Ishikawa T; Tsunoda R; Numata T; Mukai Y; Kihara Y; Koehler J; Hidaka K; Sharma V
    Circ J; 2020 Jun; 84(7):1118-1123. PubMed ID: 32448844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
    Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
    Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
    Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
    JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.